El Hospital Pablo Tobón Uribe es una institución hospitalaria de carácter privado, de origen testamentario, sin ánimo de lucro. Se encuentra ubicado en el barrio Córdoba, en la comuna Robledo de la Ciudad de Medellín, Colombia. Es una de las instituciones de salud más importantes de Colombia.​​

During the past decade, Hospital Pablo Tobon Uribe conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 52 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 30 clinical trials were completed. i.e. 214.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Pablo Tobon Uribe" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Pfizer" with 12 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "Hospital Pablo Tobón Uribe" with 4 trials sponsored and "Shire" with 4 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Pablo Tobon Uribe" #1 collaborator was "Hospital Pablo Tobón Uribe" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "OCT Clinical Trials" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Pablo Tobon Uribe" are "Rheumatoid Arthritis" (8 trials), "Systemic Lupus Erythematosus" (6 trials), "Lupus Nephritis" (4 trials), "Multiple Myeloma" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Hospital Pablo Tobon Uribe" in a lesser frequency.

Most popular intervention types in "Hospital Pablo Tobon Uribe" are "Drug" (73 trials), "Other" (13 trials), "Biological" (11 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Prednisone" (4 trials), "Docetaxel" (3 trials), "GDC-0853" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Pablo Tobon Uribe" are 87 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Pablo Tobon Uribe". undefined are not yet recruiting, 7 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Hospital Pablo Tobon Uribe, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Pablo Tobon Uribe, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 6 trials that are defined as “Not Applicable".